CLINICAL_TRIALS
trial_result
· 2012-12-06
Clinical Trial Update: Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis [Phase 2]
Summary
Phase 2 clinical trial evaluating anti-atherosclerotic activity of Inflaminat in asymptomatic individuals with subclinical carotid atherosclerosis; current stat…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Institute for Atherosclerosis Research, Russia | Conditions: Carotid Atherosclerosis | Phase 2 | Status: UNKNOWN